These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 633697)

  • 1. [The immunopotentiating action of BCG and its various effects on tumors (author's transl)].
    Yamada H
    Kekkaku; 1978 Jan; 53(1):11-23. PubMed ID: 633697
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
    Simmons RL; Rios A
    Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
    [No Abstract]   [Full Text] [Related]  

  • 3. Concomitant immunity and specific desensitization in murine tumor hosts.
    Vaage J
    Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of regional lymphadenectomy on development of concomitant immunity.
    Soloway MS; Pendergrast WJ; Myers GH
    Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
    [No Abstract]   [Full Text] [Related]  

  • 7. Lectin potentiation of BCG-contact-mediated antitumor action.
    Poduval TB; Seshadri M; Sundaram K
    J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-GuĂ©rin and tumor cells.
    Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
    Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the mode of the immunopotentiating action of BCG (Part 2) (author's transl)].
    Harada Y
    Kekkaku; 1977 Nov; 52(11):541-7. PubMed ID: 599774
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.
    Paranjpe MS; Boone CW
    J Natl Cancer Inst; 1972 Feb; 48(2):563-6. PubMed ID: 4347042
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced growth of fibrosarcoma in mice treated with phytohemagglutinin.
    Wagener DJ
    Cancer Res; 1973 Jun; 33(6):1295-300. PubMed ID: 4718679
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adoptive immunotherapy of Gross virus-induced or-infected tumors in Gross tolerant rats (author's transl)].
    Takeichi N; Kuzumaki N; Kobayashi H
    Hokkaido Igaku Zasshi; 1974 May; 49(3):206-12. PubMed ID: 4480371
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of tuberculin and phytohemagglutinin skin tests by large tumors in inbred mice.
    Wells JH; Cain WA; Wells RS; Bozalis JR
    Int Arch Allergy Appl Immunol; 1974; 47(3):362-8. PubMed ID: 4430503
    [No Abstract]   [Full Text] [Related]  

  • 18. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 20. The antigenicity and immunogenicity of cell-free extracts of chemically induced murine sarcomas.
    Pilch YH
    Cancer Res; 1968 Dec; 28(12):2502-11. PubMed ID: 4302533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.